Boehringer Ingelheim Corporation And Yale University Collaborate To Investigate Novel Immunotherapy Targets Across Several Therapeutic Areas
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim announced today collaboration with Yale University, New Haven, Connecticut, USA, with the goal of researching novel therapeutic targets in the field of immune-modulation. Immune-modulation refers to a range of treatments aimed at harnessing a patient’s immune system to fight disease.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.